INCOG BioPharma Services

United States Founded: 2020 • Age: 6 yrs
Injectable drug products are manufactured by this biopharma CDMO.

About INCOG BioPharma Services

INCOG BioPharma Services is a Healthcare company based in United States founded in 2020 by Cory Lewis and Tedd Green. Injectable drug products are manufactured by this biopharma CDMO. INCOG BioPharma Services has raised $86.63 million across 5 funding rounds. Its chief executive, as recorded, is Cory Lewis. INCOG BioPharma Services offers products and services including Drug Development Services, Manufacturing Services, and Analytical and Quality Control. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is INCOG BioPharma Services, Inc. Its competitors include Exela Pharma, Summit Biosciences and ApiJect; 2 of its 3 listed competitors have raised funding.

Company details

INCOG BioPharma Services was founded in 2020 in the United States as a contract development and manufacturing organization. Emphasis is placed on the production of injectable drug products within the biopharmaceutical sector. Services encompass drug product manufacturing for clients, with operations based domestically. The company was co-founded by Cory Lewis, serving as CEO, and Tedd Green, serving as COO, supporting pharmaceutical development needs.

  • Headquarters United States
  • Founders Cory Lewis, Tedd Green
  • Sectors
    Healthcare
  • Website incogbiopharma.com
  • Social LinkedIn
  • Legal Name Incog Biopharma Services, Inc.
Key Metrics
  • Total Equity Funding
    $86.63M (USD)

    in 5 rounds

  • Latest Funding Round
    $42.86M (USD), Series C

    May 2024

Products & Services of INCOG BioPharma Services

INCOG BioPharma Services offers a comprehensive portfolio of products and services, including Drug Development Services, Manufacturing Services, and Analytical and Quality Control.

Drug Development Services
R&D Services

Assists in developing injectable drug products for market acceleration

Manufacturing Services
Production Services

Manufactures injectable drugs using advanced facilities and quality controls

Analytical and Quality Control
Testing Services

Provides testing for drug safety and compliance in pharmaceutical processes

Funding Insights of INCOG BioPharma Services

INCOG BioPharma Services has successfully raised a total of $86.63M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $42.86 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $86.63M
  • Total Rounds 5
  • Last Round Series C β€” $42.86M
  • First Round $28.77M

    (Sep 2020)

All 5 funding rounds of INCOG BioPharma Services with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2024$42.86MSeries C––
–
Apr 2022Debt – Conventional––
–
Apr 2022$15MSeries B––
–
Sep 2020$28.77MSeries B––
–
Sep 2020Debt – Conventional––
–

People of INCOG BioPharma Services

2 people are tracked at INCOG BioPharma Services (2 in leadership).

NameRoleGroup
Cory Lewis
Co-Founder & CEOLeadership
Tedd Green
Co-Founder & COOLeadership
Premium access

Complete people profiles for INCOG BioPharma Services

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of INCOG BioPharma Services

3 dated milestones of INCOG BioPharma Services across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded INCOG BioPharma Services is founded.
  2. Funding First funding round of $28.8M.
  3. Funding Latest funding round, Series C, of $42.9M.

Competitors of INCOG BioPharma Services

INCOG BioPharma Services has 3 listed competitors in our database, 2 of them funded. They include Exela Pharma, Summit Biosciences and ApiJect.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
exelapharma.com2005Lenoir, United States$7.09M247
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
summitbiosciences.com2008Lexington, United States
Nasal spray drug products are developed, manufactured, and commercialized.
apiject.com2015Stamford, United States$111M
Medicine injectors are manufactured by ApiJect for medical applications.
Premium access

Detailed competitors of INCOG BioPharma Services

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of INCOG BioPharma Services

The website of INCOG BioPharma Services (incogbiopharma.com) receives about 3.6K visits a month.

  • Monthly visits
    3.6K

    ▼ 10.2% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as INCOG BioPharma Services (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Incog Biopharma Services

Premium access

Complete news archive for INCOG BioPharma Services

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about INCOG BioPharma Services

INCOG BioPharma Services was founded in 2020.

INCOG BioPharma Services is headquartered in United States.

Cory Lewis is the CEO of INCOG BioPharma Services, as recorded in our data. They have also founded this company.

INCOG BioPharma Services is a funded company, having raised a total of $86.63M across 5 funding rounds to date. The company's 1st funding round was a Series B of $28.77M, raised on Sep 2020.

INCOG BioPharma Services was founded in 2020 in the United States as a contract development and manufacturing organization. Emphasis is placed on the production of injectable drug products within the biopharmaceutical sector. Services encompass drug product manufacturing for clients, with operations based domestically. The company was co-founded by Cory Lewis, serving as CEO, and Tedd Green, serving as COO, supporting pharmaceutical development needs.

INCOG BioPharma Services's top competitors include Exela Pharma, Summit Biosciences and ApiJect.

INCOG BioPharma Services offers Drug Development Services, Manufacturing Services, and Analytical and Quality Control.

INCOG BioPharma Services operates through Incog Biopharma Services, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available